Jaguar Health, Inc. will effect a 1-for-15 reverse stock split of its issued and outstanding voting common stock on Thursday, September 17, 2026, in order to support the Company's compliance with Nasdaq's listing standards. The Company's common stock will begin trading on a split-adjusted basis when the market opens on the Effective Date and will remain listed on The Nasdaq Capital Market under the symbol JAGX, with a new CUSIP number of 47010C854. The reverse stock split follows stockholder approval of a proposal submitted at the Company's April 2026 Special Meeting of Stockholders, described in the definitive proxy statement on Schedule 14A filed with the Securities and Exchange Commission on March 24, 2026. When the split becomes effective, every fifteen shares of common stock immediately prior to the Effective Date will automatically be reclassified into one share, with no change in par value per share, and no fractional shares will be issued, with stockholders entitled to a fractional share receiving a cash payment in lieu thereof. Equiniti Trust Company, LLC is acting as exchange agent and will send instructions to stockholders of record holding stock certificates, while stockholders holding shares in brokerage accounts or street name are not required to take any action.
Jaguar Animal Health IncJaguar Health will effect a 1-for-15 reverse stock split to support compliance with Nasdaq listing standards.
